Dementia - Articles - Page 5 | CARLAT PUBLISHING

Mediterranean Diet and Age-Related Cognitive Decline: A Randomized Clinical Trial

July 1, 2015

Review of this study regarding the effects of a Mediterranean diet on age-related cognitive decline: Valis-Pedret C et al, JAMA Intern Med 2015. 11.doi:10.1001/jamainternmed.2015.1668. Epub ahead of print.

Namzaric and Other Cognitive Enhancers for Dementia

March 1, 2015

Daniel Carlat, MD

Daniel Carlat, MD

Editor-in-Chief, Publisher, The Carlat Report.

Dr. Carlat has disclosed that he has no relevant relationships or financial interests in any commercial company pertaining to this educational activity.

There’s a new medication on the market for the treatment of dementia—the first to come along in several years.

Benzodiazepine Use and Alzheimer’s Risk

March 1, 2015

Daniel Carlat, MD

Daniel Carlat, MD

Editor-in-Chief, Publisher, The Carlat Report.

Dr. Carlat has disclosed that he has no relevant relationships or financial interests in any commercial company pertaining to this educational activity.

If you’re like most psychiatrists, you get your fair share of older folks who come into the office complaining of difficulties with sleep or with significant symptoms of anxiety.

Assessing and Working with Patients with Cognitive Impairment and Dementia

March 1, 2015

Marc Agronin, MD

Marc Agronin, MD Geriatric Psychiatrist Vice President, Behavioral Health and Clinical Research Miami Jewish Health Systems, Miami, FL Dr. Agronin has disclosed that he is principal investigator on research grants from several pharmaceutical firms and that all funds go directly to his employer, Miami Jewish Health Systems. In addition, he has been on the speakers bureaus of Forest Laboratories (Namenda XR), AssurX (GeneSightRX), and Novartis (Exelon Patch). Dr. Carlat has reviewed the content of the interview and has determined that there is no bias due to these relationships.

Get advice on how to assess and work with patients with cognitive impairment and dementia, in an interview with Marc Agronin, MD, Geriatric Psychiatrist and Vice President of Behavioral Health and Clinical Research at Miami Jewish Health Systems.

Anticholinergics and Dementia

March 1, 2015

Many medications have anticholinergic side effects, which can be particularly troublesome for the elderly.

Personality May Influence the Risk for Alzheimer’s

November 1, 2014

It’s commonly known that the risk of developing dementia is related to education level, history of head trauma, family history, and genetics. But could personality also play a role?

Healthy Lifestyle Can Lower Dementia Risk

January 12, 2014

Joanne Finnegan

...

Current Pharmacological Treatment of Dementia

October 1, 2013

Cary S. Gunther, PhD

Cary S. Gunther, PhD Neurologist and psychiatrist in private practice, Voluntary Faculty, New York Presbyterian-Weill Cornell Medical Center Dr. Gunther has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Patients with dementia and their families may express frustration about the limited number of options for improving cognitive symptoms, but they are not without choices. Here we will review a number of pharmacological treatment options for Alzheimer’s disease (AD) and other major types of dementia.

Table - Types of Dementia

October 1, 2013

Documents: Table - Types of Dementia.pdf...

Psychiatric Illness in the Elderly

October 1, 2013

Dan G. Blazer, PhD, MD

Dan G. Blazer, PhD, MD Vice Chair, Department of Psychiatry and Behavioral Sciences, Vice Chair, Academic Development, Duke University Dr. Blazer has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Duke University’s Dr. Dan Blazer explains special considerations for treating psychiatric disorders in the elderly.